Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Oct 20, 2022 4:25pm
410 Views
Post# 35037429

Gunner who do you think the judge will believe

Gunner who do you think the judge will believePrometics scientists with great reputations or the people who got rid of them and replaced them with their scientist who all of a sudden state results presented to retail investors in 2017,2018,2019 by prometics scientists and pierre laurin that where very good now are no longer good and they stopped research and sold plasma division like ryplasim molecule for peanuts just before fda approval

since takeover wiping out retail investors what as management done to improve shareholders value and what did the accomplish re research 

they did pay themselves big salaries and paid back the loans 
retail investors never got anything
<< Previous
Bullboard Posts
Next >>